Aurinia Pharmaceuticals
AUPH
#5140
Rank
A$1.96 B
Marketcap
$13.70
Share price
0.68%
Change (1 day)
-1.65%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): -A$64.53 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are A$0.20 Billion. In 2023 the company made an earning of -A$0.12 Billion, an increase over its 2022 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$64.53 Million-43.77%
2023 -A$0.12 Billion-31.8%
2022 -A$0.17 Billion-39.4%
2021 -A$0.28 Billion61.9%
2020 -A$0.18 Billion-9.73%
2019 -A$0.19 Billion92.85%
2018 -A$98.52 Million36.25%
2017 -A$72.31 Million106.29%
2016 -A$35.05 Million-15.4%
2015 -A$41.43 Million65.84%
2014 -A$24.99 Million129.82%
2013 -A$10.87 Million-26.6%
2012 -A$14.81 Million
2010 -A$8.39 Million-39.22%
2009 -A$13.8 Million-43.78%
2008 -A$24.54 Million-53.19%
2007 -A$52.43 Million42.97%
2006 -A$36.67 Million-23.03%
2005 -A$47.65 Million36.1%
2004 -A$35.01 Million172.57%
2003 -A$12.85 Million484.61%
2002 -A$2.2 Million
2000 -A$10.44 Million453.81%
1999 -A$1.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$7.63 B-11,682.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$8.43 Million-87.22%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$23.45 Million-64.44%๐Ÿ‡บ๐Ÿ‡ธ USA